For more information contact goharmonisation@gmail.com
4.30 p.m.
Barbara Altieri
Managing mitotane treatment in ACC with a focus on adverse effects.
5.00 p.m.
Christina Pamporaki
Are there any tools on the horizon to replace the ARR for screening for PA?
5.30 p.m.
Gauthier Chassang
Ethical and regulatory aspects in sharing clinical data (and samples) for research between EU countries.
6.00 p.m.
Rodrigo Toledo & Cristina Ronchi
Liquid biopsy in adrenal tumors - which method to use and when?
Alessandro Prete
How reliable are the results of a single 1mg dexamethasone test in patients with adrenal incidentalomas?
Tracy Williams
Debulking surgery for PA: is a fundamental dogma in the management of PA falling?
Guillaume Assie
ENSAT registry. Legal and ethical considerations.
Eric Baudin
Malignant PPGL - how does FIRST-MAPPP change the treatment landscape?
COST is an EU funding programme that enables researchers to set up their interdisciplinary research networks in Europe and beyond. We provide funds for organising conferences, meetings, training schools, short scientific exchanges or other networking activities in a wide range of scientific topics. By creating open spaces where people and ideas can grow, we unlock the full potential of science.
Harmonis@tion aims to constitute a multidisciplinary network to harmonize clinical care and research on adrenal tumours throughout Europe with a focus on COST Inclusiveness Target Countries. In addition, this collaborative network will establish a modern framework to develop a new generation of real-time and real-life randomized clinical trials, which will be federated and registry-based.
Start of Action: 28/09/2021
End of Action: 27/09/2025
Some photos from the last scientific eMeeting:
